Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma

被引：0
|
作者：
Takanami, I [1 ]
Takeuchi, K [1 ]
Naruke, M [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg 1, Itabashi Ku, Tokyo 173, Japan
来源：
ONCOLOGY REPORTS | 2000年 / 7卷 / 05期
关键词：
CD44S; prognostic indicator; pulmonary adenocarcinoma; tumor progression; metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We examined immunohistochemically the expression of the standard form of CD44 (CD44S) tissue specimens from 164 patients with pulmonary adenocarcinoma. Of the 164 specimens, 79 (48%) expressed CD33S and the incidence of expression correlated with the tumor size. The prognosis for CD44S positive patients was poorer than that of CD44S negative patients. Our findings suggest that CD44S plays an important role in tumor progression and that CD44S expression is a useful prognostic market for pulmonary adenocarcinomas.
引用
收藏
页码：1065 / 1067
页数：3
相关论文
共 50 条
  • [31] Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
    Humphrey, G
    Hazel, DL
    MacLennan, K
    Lewis, I
    BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 918 - 921
  • [32] Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study
    Minardi, Daniele
    Lucarini, Guendalina
    Filosa, Alessandra
    Zizzi, Antonio
    Simonetti, Oriana
    Offidani, Anna Maria
    d'Anzeo, Gianluca
    Di Primio, Roberto
    Montironi, Rodolfo
    Muzzonigro, Giovanni
    CELLULAR ONCOLOGY, 2012, 35 (05) : 377 - 384
  • [33] Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
    G Humphrey
    D L Hazel
    K MacLennan
    I Lewis
    British Journal of Cancer, 1999, 80 : 918 - 921
  • [34] Prognostic Impact of CD44 Expression in Patients With Myxofibrosarcoma
    Tsuchie, Hiroyuki
    Emori, Makoto
    Miyakoshi, Naohisa
    Nagasawa, Hiroyuki
    Okada, Kyoji
    Nanjyo, Hiroshi
    Murahashi, Yasutaka
    Mizushima, Emi
    Shimizu, Junya
    Yamashita, Toshihiko
    Shimada, Yoichi
    IN VIVO, 2019, 33 (06): : 2095 - 2102
  • [35] Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
    Yangkun Luo
    Yan Tan
    Cancer Cell International, 16
  • [36] Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
    Cema, Ingrida
    Dzudzilo, Madara
    Kleina, Regina
    Franckevica, Ivanda
    Svirskis, Simons
    CANCERS, 2021, 13 (22)
  • [37] CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids
    Swarts, Dorian R. A.
    Henfling, Mieke E. R.
    Van Neste, Leander
    van Suylen, Robert-Jan
    Dingemans, Anne-Marie C.
    Dinjens, Winand N. M.
    Haesevoets, Annick
    Rudelius, Martina
    Thunnissen, Erik
    Volante, Marco
    Van Criekinge, Wim
    van Engeland, Manon
    Ramaekers, Frans C. S.
    Speel, Ernst-Jan M.
    CLINICAL CANCER RESEARCH, 2013, 19 (08) : 2197 - 2207
  • [38] Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer
    Aaltomaa, S
    Lipponen, P
    Ala-Opas, M
    Kosma, VM
    EUROPEAN UROLOGY, 2001, 39 (02) : 138 - 144
  • [39] CD44 and OTP are Strong Prognostic Markers for Pulmonary Carcinoids
    Swarts, D. R. A.
    Henfling, M.
    van Neste, L.
    van Suylen, R.
    Dingemans, A. M.
    Dinjens, W. N. M.
    Haesevoets, A.
    Rudelius, M.
    Thunnissen, F. B. J.
    Volante, M.
    van Criekinge, W.
    van Engeland, M.
    Ramaekers, F. C. S.
    Speel, E. J. M.
    JOURNAL OF PATHOLOGY, 2013, 229 : S6 - S6
  • [40] CD44 expression in glandular lesions and adenocarcinoma of the uterine cervix
    Danilova, N. V.
    Andreeva, Y. Y.
    Malkov, P. G.
    Zavalishina, L. E.
    Frank, G. A.
    VIRCHOWS ARCHIV, 2011, 459 : S231 - S232
12345